The Potential of Vitamin D and Epigallocatechin Gallate (EGCG) for the Treatment of Uterine Fibroids: Evidence From In Vitro to Clinical Studies
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Ioanna Ploumaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Catechin, Leiomyoma, Vitamin D, Uterine Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Howard W. and Georgeanna Seegar Jones Endowment, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Uterine fibroids are prevalent benign tumors of the female reproductive tract that cause significant morbidity. Accumulating evidence suggests an association between vitamin D deficiency and uterine fibroid prevalence. Vitamin D, synthesized through sunlight exposure and obtained from fatty fish and fortified foods, regulates key processes, such as cell proliferation and apoptosis. In vitro and in vivo studies have demonstrated the efficacy of vitamin D against uterine fibroids. Clinical evidence further supports its role in fibroid management, as evidenced by a decrease in fibroid incidence, volume, and growth rate. Similarly, EGCG, a major polyphenol in green tea, inhibits cell proliferation and fibrosis while inducing apoptosis. Both in vitro and in vivo studies reveal the potential of EGCG in fibroid treatment, with clinical trials corroborating these findings. Given their complementary mechanisms, a synergistic effect of combined vitamin D and EGCG treatment has been explored. Preliminary clinical evidence indicates promising results, including reduction in fibroid volume, improved surgical outcomes, and enhanced quality of life. This review synthesizes current knowledge of vitamin D and EGCG mechanisms of action, presents preclinical and clinical evidence, and discusses the emerging evidence for their combination therapy as a non‐invasive, cost‐effective treatment strategy for uterine fibroids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Gynecology and Obstetrics, Division of Reproductive Sciences & Women's Health Research, Johns Hopkins Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Md Soriful Islam
Förderung
- NICHD NIH HHS
- Howard W. and Georgeanna Seegar Jones Endowment
- National Institute of Child Health and Human Development
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ploumaki, I., El Sayed, S., Asamoah-Mensah, A., Macri, V. I., Segars, J. H., & Islam, M. S. (2025). The Potential of Vitamin D and Epigallocatechin Gallate (EGCG) for the Treatment of Uterine Fibroids: Evidence From In Vitro to Clinical Studies. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70231
Vancouver
Ploumaki I, El Sayed S, Asamoah-Mensah A, Macri VI, Segars JH, Islam MS. The Potential of Vitamin D and Epigallocatechin Gallate (EGCG) for the Treatment of Uterine Fibroids: Evidence From In Vitro to Clinical Studies. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70231
BibTeX
@article{Ploumaki2025,
author = {Ploumaki, Ioanna and El Sayed, Samya and Asamoah-Mensah, Awurakua and Macri, Valeria I and Segars, James H and Islam, Md Soriful},
title = {The Potential of Vitamin D and Epigallocatechin Gallate (EGCG) for the Treatment of Uterine Fibroids: Evidence From In Vitro to Clinical Studies},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70231}
}
EUVIMED